Back to Search

Screening for Alzheimer's Disease Studies

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Recruiting Phase 3 Interventional Study
Alzheimers Disease
More trials: Alzheimer's clinical trials· Alzheimer's trials in Alabama
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 90
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Screening
Participants needed
80,000 (estimated)
Sponsor
Hoffmann-La Roche · Industry
Who this trial is looking for

This trial is looking for individuals who may qualify for Alzheimer's disease research studies. Participants will be assessed to see if they can join related interventional studies.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am willing to take part in a clinical study.
  • I can understand information about my eligibility for related studies.

You may not be able to join if

  • I need help with basic daily activities due to cognitive issues.
  • I have visual or hearing impairments that prevent me from completing cognitive tests.
  • I have any neurological condition that affects my thinking ability, other than Alzheimer's disease.
  • I have had severe brain injury in the past.
  • I have a serious medical condition that would make it unsafe for me to participate.
  • I have been diagnosed with mild cognitive impairment or mild Alzheimer's disease based on certain approved tests.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ability and willingness to participate in an interventional clinical study, including meeting key eligibility criteria of linked interventional Roche AD studies (e.g., specific age ranges) * Ability and willingness to receive information about potential eligibility in an assoc…
Contacts

Reference Study ID Number: WP45722 https://forpatients.roche.com/ No attachments to email below.

888-662-6728 (U.S. and Canada)

global-roche-genentech-trials@gene.com

CONTACT

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

CONTACT

NCT ID: NCT07177352 Source: ClinicalTrials.gov